The initial term of the agreement begins on March 21, 2011 and ends on March 20, 2014 (the “start period”). The agreement may be renewed each year, with the agreement of the parties, for an additional twelve (12) months (an “extension period” and a “duration” with the initial duration). The parties undertake to communicate in writing to the other party of their intention to extend the agreement at least sixty (60) days before the current period expires. The parties agree that each party is not liable for the negligence or omission of the agents or employees of the other party. This agreement should not be construed as requiring a party to compensate another party for its negligence, actions or omissions. The Arkansas Constitution prohibits uAMS, as a sovereign entity, from entering into third-party compensation agreements. This agreement cannot be construed as lifting the sovereign immunity of the State of Arkansas or its units, including UAMS; nor does it constitute a waiver of the legal requirements for filing a claim against the State of Arkansas, its entities or UAMS, which must be submitted to the Arkansas Claims Commission. CONSIDERING that UAMS operates a clinical laboratory for the benefit of the patients it cares for and that it needs the services of a qualified reference laboratory capable of conducting diagnostic tests of genetic tables that the hospital cannot perform in its own laboratory; LABORATORY undertakes to provide transition services to uamS after the date of the date and material, in accordance with the written provisions and provisions of the parties. The termination does not exonerate, exonerate or exonerate any of the parties that originated prior to the termination of this contract and which still have to be completed at the time of termination, including, but not limited to the obligation of LABORATORY to provide the services declared to uAMS, and the obligation of UAMS to award compensation to LABOR. In particular, if the contract is terminated for any reason, UAMS PAIE LABORATORY and LABORATORY is authorized to withhold all outstanding costs for services provided by LABORATORY. UAMS ensures that all services provided under this directive are provided in accordance with established and recognized laboratory clinical trial procedures with appropriate diligence, in accordance with applicable federal, regional and local laws. The other guarantees are not linked by labs.
Under no circumstances will LABORATORY be responsible for any subsequent or special damage caused by UAMS or third parties. This Covid-19 Laboratory Services Agreement (“Agreement”) is signed between Co-Diagnostics, Inc., a Utah company headquartered in 2401 South Foothill Drive, Suite D, Salt Lake City, UT 84109 (`Customer`) and Arches Research, Inc., a Nevada company that is its main business in 1960 S 4250 W, Salt Lake City, UT 84104 (`Arches`) (respectively called “party”) If this agreement is signed by both parties , the conditions under which Arches undertakes to provide customer-specific services are defined in this context.